메뉴 건너뛰기




Volumn 27, Issue 4, 2013, Pages 785-804

Challenges in the treatment of older breast cancer patients

Author keywords

Age; Aged; Breast cancer; Elderly; Geriatric

Indexed keywords

AROMATASE INHIBITOR; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN; TRASTUZUMAB; TRASTUZUMAB EMTANSINE;

EID: 84881318456     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2013.05.008     Document Type: Review
Times cited : (15)

References (84)
  • 4
    • 0142008446 scopus 로고    scopus 로고
    • Undertreatment strongly decreases prognosis of breast cancer in elderly women
    • Bouchardy C., Rapiti E., Fioretta G., et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. JClin Oncol 2003, 21(19):3580-3587.
    • (2003) JClin Oncol , vol.21 , Issue.19 , pp. 3580-3587
    • Bouchardy, C.1    Rapiti, E.2    Fioretta, G.3
  • 5
    • 83355174078 scopus 로고    scopus 로고
    • Improvement in breast cancer outcomes over time: are older women missing out?
    • Eng
    • Smith B.D., Jiang J., McLaughlin S.S., et al. Improvement in breast cancer outcomes over time: are older women missing out?. JClin Oncol 2011, 29:4647-4653. Eng.
    • (2011) JClin Oncol , vol.29 , pp. 4647-4653
    • Smith, B.D.1    Jiang, J.2    McLaughlin, S.S.3
  • 6
    • 33947425240 scopus 로고    scopus 로고
    • Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women
    • Owusu C., Lash T.L., Silliman R.A. Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women. Breast Cancer Res Treat 2007, 102(2):227-236.
    • (2007) Breast Cancer Res Treat , vol.102 , Issue.2 , pp. 227-236
    • Owusu, C.1    Lash, T.L.2    Silliman, R.A.3
  • 7
    • 84859140429 scopus 로고    scopus 로고
    • Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
    • Biganzoli L., Wildiers H., Oakman C., et al. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 2012, 13(4):e148-e160.
    • (2012) Lancet Oncol , vol.13 , Issue.4
    • Biganzoli, L.1    Wildiers, H.2    Oakman, C.3
  • 8
    • 84874586547 scopus 로고    scopus 로고
    • Adjuvant therapy of breast cancer in women 70years of age and older: tough decisions, high stakes
    • Jones E.L., Leak A., Muss H.B. Adjuvant therapy of breast cancer in women 70years of age and older: tough decisions, high stakes. Oncology (Williston Park) 2012, 26(9):793-801.
    • (2012) Oncology (Williston Park) , vol.26 , Issue.9 , pp. 793-801
    • Jones, E.L.1    Leak, A.2    Muss, H.B.3
  • 9
    • 0037018496 scopus 로고    scopus 로고
    • Understanding the treatment preferences of seriously ill patients
    • Fried T.R., Bradley E.H., Towle V.R., et al. Understanding the treatment preferences of seriously ill patients. NEngl J Med 2002, 346(14):1061-1066.
    • (2002) NEngl J Med , vol.346 , Issue.14 , pp. 1061-1066
    • Fried, T.R.1    Bradley, E.H.2    Towle, V.R.3
  • 10
    • 84881318431 scopus 로고    scopus 로고
    • ePrognosis. 2012. Available at: Accessed February 12
    • Lee S, Smith AK, Widera EW, etal. ePrognosis. 2012. Available at: Accessed February 12, 2013. http://www.eprognosis.org.
    • (2013)
    • Lee, S.1    Smith, A.K.2    Widera, E.W.3
  • 11
    • 84862909269 scopus 로고    scopus 로고
    • Prognostic indices for older adults: a systematic review
    • Yourman L.C., Lee S.J., Schonberg M.A., et al. Prognostic indices for older adults: a systematic review. JAMA 2012, 307(2):182-192.
    • (2012) JAMA , vol.307 , Issue.2 , pp. 182-192
    • Yourman, L.C.1    Lee, S.J.2    Schonberg, M.A.3
  • 12
    • 0035865149 scopus 로고    scopus 로고
    • Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer
    • Ravdin P.M., Siminoff L.A., Davis G.J., et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. JClin Oncol 2001, 19(4):980-991.
    • (2001) JClin Oncol , vol.19 , Issue.4 , pp. 980-991
    • Ravdin, P.M.1    Siminoff, L.A.2    Davis, G.J.3
  • 13
    • 4444315066 scopus 로고    scopus 로고
    • Probabilities of death from breast cancer and other causes among female breast cancer patients
    • Schairer C., Mink P.J., Carroll L., et al. Probabilities of death from breast cancer and other causes among female breast cancer patients. JNatl Cancer Inst 2004, 96(17):1311-1321.
    • (2004) JNatl Cancer Inst , vol.96 , Issue.17 , pp. 1311-1321
    • Schairer, C.1    Mink, P.J.2    Carroll, L.3
  • 14
    • 0037080281 scopus 로고    scopus 로고
    • Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study
    • Repetto L., Fratino L., Audisio R.A., et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. JClin Oncol 2002, 20(2):494-502.
    • (2002) JClin Oncol , vol.20 , Issue.2 , pp. 494-502
    • Repetto, L.1    Fratino, L.2    Audisio, R.A.3
  • 15
    • 79952628117 scopus 로고    scopus 로고
    • Screening older cancer patients for a Comprehensive Geriatric Assessment: a comparison of three instruments
    • Owusu C., Koroukian S.M., Schluchter M., et al. Screening older cancer patients for a Comprehensive Geriatric Assessment: a comparison of three instruments. JGeriatr Oncol 2011, 2:121-129.
    • (2011) JGeriatr Oncol , vol.2 , pp. 121-129
    • Owusu, C.1    Koroukian, S.M.2    Schluchter, M.3
  • 16
    • 34249774066 scopus 로고    scopus 로고
    • Comprehensive geriatric assessment for older patients with cancer
    • Extermann M., Hurria A. Comprehensive geriatric assessment for older patients with cancer. JClin Oncol 2007, 25(14):1824-1831.
    • (2007) JClin Oncol , vol.25 , Issue.14 , pp. 1824-1831
    • Extermann, M.1    Hurria, A.2
  • 17
    • 24044454968 scopus 로고    scopus 로고
    • Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)
    • Extermann M., Aapro M., Bernabei R., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005, 55(3):241-252.
    • (2005) Crit Rev Oncol Hematol , vol.55 , Issue.3 , pp. 241-252
    • Extermann, M.1    Aapro, M.2    Bernabei, R.3
  • 18
    • 84855701468 scopus 로고    scopus 로고
    • Validation of the G8 screening tool in geriatric oncology: the ONCODAGE project
    • Soubeyran P., Bellera C., Goyard J., et al. Validation of the G8 screening tool in geriatric oncology: the ONCODAGE project. JClin Oncol 2011, 29(15S):550S.
    • (2011) JClin Oncol , vol.29 , Issue.15 S
    • Soubeyran, P.1    Bellera, C.2    Goyard, J.3
  • 19
    • 33846905273 scopus 로고    scopus 로고
    • Apilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation
    • Mohile S.G., Bylow K., Dale W., et al. Apilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer 2007, 109(4):802-810.
    • (2007) Cancer , vol.109 , Issue.4 , pp. 802-810
    • Mohile, S.G.1    Bylow, K.2    Dale, W.3
  • 20
    • 77951624378 scopus 로고    scopus 로고
    • Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13
    • Luciani A., Ascione G., Bertuzzi C., et al. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. JClin Oncol 2010, 28(12):2046-2050.
    • (2010) JClin Oncol , vol.28 , Issue.12 , pp. 2046-2050
    • Luciani, A.1    Ascione, G.2    Bertuzzi, C.3
  • 21
    • 79952912927 scopus 로고    scopus 로고
    • Screening for a geriatric risk profile in older cancer patients: a comparative study of the predictive validity of three screening tools
    • Kenis C., Schuermans H., Van Custem E., et al. Screening for a geriatric risk profile in older cancer patients: a comparative study of the predictive validity of three screening tools. Crit Rev Oncol Hematol 2009, 72(Suppl):22.
    • (2009) Crit Rev Oncol Hematol , vol.72 , Issue.SUPPL , pp. 22
    • Kenis, C.1    Schuermans, H.2    Van Custem, E.3
  • 22
    • 79953836199 scopus 로고    scopus 로고
    • Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401
    • Hurria A., Cirrincione C.T., Muss H.B., et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. JClin Oncol 2011, 29(10):1290-1296.
    • (2011) JClin Oncol , vol.29 , Issue.10 , pp. 1290-1296
    • Hurria, A.1    Cirrincione, C.T.2    Muss, H.B.3
  • 23
    • 79955043830 scopus 로고    scopus 로고
    • Association of cancer with geriatric syndromes in older Medicare beneficiaries
    • Mohile S.G., Fan L., Reeve E., et al. Association of cancer with geriatric syndromes in older Medicare beneficiaries. JClin Oncol 2011, 29(11):1458-1464.
    • (2011) JClin Oncol , vol.29 , Issue.11 , pp. 1458-1464
    • Mohile, S.G.1    Fan, L.2    Reeve, E.3
  • 24
    • 84862575323 scopus 로고    scopus 로고
    • Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
    • Extermann M., Boler I., Reich R.R., et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 2012, 118(13):3377-3386.
    • (2012) Cancer , vol.118 , Issue.13 , pp. 3377-3386
    • Extermann, M.1    Boler, I.2    Reich, R.R.3
  • 25
    • 80052704591 scopus 로고    scopus 로고
    • Predicting chemotherapy toxicity in older adults with cancer: a Prospective Multicenter Study
    • Hurria A., Togawa K., Mohile S.G., et al. Predicting chemotherapy toxicity in older adults with cancer: a Prospective Multicenter Study. JClin Oncol 2011, 29(25):3457-3465.
    • (2011) JClin Oncol , vol.29 , Issue.25 , pp. 3457-3465
    • Hurria, A.1    Togawa, K.2    Mohile, S.G.3
  • 26
    • 78650717087 scopus 로고    scopus 로고
    • Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
    • Correa C., McGale P., Taylor C., et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. JNatl Cancer Inst Monographs 2010, 2010(41):162-177.
    • (2010) JNatl Cancer Inst Monographs , vol.2010 , Issue.41 , pp. 162-177
    • Correa, C.1    McGale, P.2    Taylor, C.3
  • 27
    • 33644972703 scopus 로고    scopus 로고
    • Prospective study of wide excision alone for ductal carcinoma in situ of the breast
    • Wong J.S., Kaelin C.M., Troyan S.L., et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. JClin Oncol 2006, 24(7):1031-1036.
    • (2006) JClin Oncol , vol.24 , Issue.7 , pp. 1031-1036
    • Wong, J.S.1    Kaelin, C.M.2    Troyan, S.L.3
  • 28
    • 73949085809 scopus 로고    scopus 로고
    • Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group
    • Hughes L.L., Wang M., Page D.L., et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. JClin Oncol 2009, 27(32):5319-5324.
    • (2009) JClin Oncol , vol.27 , Issue.32 , pp. 5319-5324
    • Hughes, L.L.1    Wang, M.2    Page, D.L.3
  • 29
    • 84881312594 scopus 로고    scopus 로고
    • RTOG 9804: a prospective randomized trial for "good risk" ductal carcinoma in situ (DCIS), comparing radiation (RT) to observation (OBS).
    • JClin Oncol 2012;30(suppl):p. abstract
    • McCormick B. RTOG 9804: a prospective randomized trial for "good risk" ductal carcinoma in situ (DCIS), comparing radiation (RT) to observation (OBS). Chicago (IL): 2012 ASCO Annual Meeting. JClin Oncol 2012;30(suppl):p. abstract 1004.
    • Chicago (IL): 2012 ASCO Annual Meeting. , pp. 1004
    • McCormick, B.1
  • 30
    • 77953248475 scopus 로고    scopus 로고
    • Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies
    • Blows F.M., Driver K.E., Schmidt M.K., et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med 2010, 7(5):e1000279.
    • (2010) PLoS Med , vol.7 , Issue.5
    • Blows, F.M.1    Driver, K.E.2    Schmidt, M.K.3
  • 31
    • 0029759541 scopus 로고    scopus 로고
    • Annual hazard rates of recurrence for breast cancer after primary therapy
    • Saphner T., Tormey D.C., Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. JClin Oncol 1996, 14(10):2738-2746.
    • (1996) JClin Oncol , vol.14 , Issue.10 , pp. 2738-2746
    • Saphner, T.1    Tormey, D.C.2    Gray, R.3
  • 32
    • 19344364880 scopus 로고    scopus 로고
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
    • Abe O., Abe R., Enomoto K., et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365(9472):1687-1717.
    • (2005) Lancet , vol.365 , Issue.9472 , pp. 1687-1717
    • Abe, O.1    Abe, R.2    Enomoto, K.3
  • 33
    • 84862242969 scopus 로고    scopus 로고
    • Is adjuvant chemotherapy useful for women with luminal a breast cancer?
    • Coates A.S., Colleoni M., Goldhirsch A. Is adjuvant chemotherapy useful for women with luminal a breast cancer?. JClin Oncol 2012, 30(12):1260-1263.
    • (2012) JClin Oncol , vol.30 , Issue.12 , pp. 1260-1263
    • Coates, A.S.1    Colleoni, M.2    Goldhirsch, A.3
  • 34
    • 33744814477 scopus 로고    scopus 로고
    • Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
    • Paik S., Tang G., Shak S., et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. JClin Oncol 2006, 24(23):3726-3734.
    • (2006) JClin Oncol , vol.24 , Issue.23 , pp. 3726-3734
    • Paik, S.1    Tang, G.2    Shak, S.3
  • 35
    • 77951637777 scopus 로고    scopus 로고
    • Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study
    • Dowsett M., Cuzick J., Wale C., et al. Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. JClin Oncol 2010, 28(11):1829-1834.
    • (2010) JClin Oncol , vol.28 , Issue.11 , pp. 1829-1834
    • Dowsett, M.1    Cuzick, J.2    Wale, C.3
  • 36
    • 57449098840 scopus 로고    scopus 로고
    • Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers
    • Chia S., Norris B., Speers C., et al. Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers. JClin Oncol 2008, 26(35):5697-5704.
    • (2008) JClin Oncol , vol.26 , Issue.35 , pp. 5697-5704
    • Chia, S.1    Norris, B.2    Speers, C.3
  • 37
    • 77955551055 scopus 로고    scopus 로고
    • American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer
    • Burstein H.J., Prestrud A.A., Seidenfeld J., et al. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. JClin Oncol 2010, 28(23):3784-3796.
    • (2010) JClin Oncol , vol.28 , Issue.23 , pp. 3784-3796
    • Burstein, H.J.1    Prestrud, A.A.2    Seidenfeld, J.3
  • 38
    • 42949108170 scopus 로고    scopus 로고
    • Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5years of tamoxifen: NCIC CTG intergroup trial MA.17
    • Muss H.B., Tu D., Ingle J.N., et al. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5years of tamoxifen: NCIC CTG intergroup trial MA.17. JClin Oncol 2008, 26(12):1956-1964.
    • (2008) JClin Oncol , vol.26 , Issue.12 , pp. 1956-1964
    • Muss, H.B.1    Tu, D.2    Ingle, J.N.3
  • 39
    • 77952590456 scopus 로고    scopus 로고
    • Polypharmacy in older adults with cancer
    • Maggiore R.J., Gross C.P., Hurria A. Polypharmacy in older adults with cancer. Oncologist 2010, 15(5):507-522.
    • (2010) Oncologist , vol.15 , Issue.5 , pp. 507-522
    • Maggiore, R.J.1    Gross, C.P.2    Hurria, A.3
  • 40
    • 84868204335 scopus 로고    scopus 로고
    • Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
    • Murphy C.C., Bartholomew L.K., Carpentier M.Y., et al. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat 2012, 134(2):459-478.
    • (2012) Breast Cancer Res Treat , vol.134 , Issue.2 , pp. 459-478
    • Murphy, C.C.1    Bartholomew, L.K.2    Carpentier, M.Y.3
  • 41
    • 45549095232 scopus 로고    scopus 로고
    • Adherence to oral endocrine therapy for breast cancer: a nursing perspective
    • Miaskowski C., Shockney L., Chelbowski R.T. Adherence to oral endocrine therapy for breast cancer: a nursing perspective. Clin J Oncol Nurs 2008, 12(2):213-221.
    • (2008) Clin J Oncol Nurs , vol.12 , Issue.2 , pp. 213-221
    • Miaskowski, C.1    Shockney, L.2    Chelbowski, R.T.3
  • 42
    • 84856636292 scopus 로고    scopus 로고
    • Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
    • Albain K., Anderson S., Arriagada R., et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. Lancet 2012, 379(9814):432-444.
    • (2012) Lancet , vol.379 , Issue.9814 , pp. 432-444
    • Albain, K.1    Anderson, S.2    Arriagada, R.3
  • 43
    • 62449193617 scopus 로고    scopus 로고
    • Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US oncology research trial 9735
    • Jones S., Holmes F.A., O'Shaughnessy J., et al. Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US oncology research trial 9735. JClin Oncol 2009, 27(8):1177-1183.
    • (2009) JClin Oncol , vol.27 , Issue.8 , pp. 1177-1183
    • Jones, S.1    Holmes, F.A.2    O'Shaughnessy, J.3
  • 44
    • 80053253110 scopus 로고    scopus 로고
    • Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: results of an observational study
    • Freyer G., Campone M., Peron J., et al. Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: results of an observational study. Crit Rev Oncol Hematol 2011, 80(3):466-473.
    • (2011) Crit Rev Oncol Hematol , vol.80 , Issue.3 , pp. 466-473
    • Freyer, G.1    Campone, M.2    Peron, J.3
  • 45
    • 20044388527 scopus 로고    scopus 로고
    • Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer
    • Muss H.B., Woolf S., Berry D., et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 2005, 293(9):1073-1081.
    • (2005) JAMA , vol.293 , Issue.9 , pp. 1073-1081
    • Muss, H.B.1    Woolf, S.2    Berry, D.3
  • 46
    • 58149339881 scopus 로고    scopus 로고
    • Impact of chemotherapy dose intensity on cancer patient outcomes
    • Lyman G.H. Impact of chemotherapy dose intensity on cancer patient outcomes. JNatl Compr Canc Netw 2009, 7(1):99-108.
    • (2009) JNatl Compr Canc Netw , vol.7 , Issue.1 , pp. 99-108
    • Lyman, G.H.1
  • 47
    • 37049183697 scopus 로고
    • Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene
    • Slamon D.J., Clark G.M., Wong S.G., et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235(4785):177-182.
    • (1987) Science , vol.235 , Issue.4785 , pp. 177-182
    • Slamon, D.J.1    Clark, G.M.2    Wong, S.G.3
  • 48
    • 0034607235 scopus 로고    scopus 로고
    • Tumor characteristics and clinical outcome of elderly women with breast cancer
    • Diab S.G., Elledge R.M., Clark G.M. Tumor characteristics and clinical outcome of elderly women with breast cancer. JNatl Cancer Inst 2000, 92(7):550-556.
    • (2000) JNatl Cancer Inst , vol.92 , Issue.7 , pp. 550-556
    • Diab, S.G.1    Elledge, R.M.2    Clark, G.M.3
  • 49
    • 84866407689 scopus 로고    scopus 로고
    • Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study
    • Sawaki M., Mukai H., Tokudome N., et al. Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study. Breast Cancer 2012, 19(3):253-258.
    • (2012) Breast Cancer , vol.19 , Issue.3 , pp. 253-258
    • Sawaki, M.1    Mukai, H.2    Tokudome, N.3
  • 50
    • 80053539103 scopus 로고    scopus 로고
    • Adjuvant Trastuzumab in HER2-Positive Breast Cancer
    • Slamon D., Eiermann W., Robert N., et al. Adjuvant Trastuzumab in HER2-Positive Breast Cancer. NEngl J Med 2011, 365(14):1273-1283.
    • (2011) NEngl J Med , vol.365 , Issue.14 , pp. 1273-1283
    • Slamon, D.1    Eiermann, W.2    Robert, N.3
  • 51
    • 84865432875 scopus 로고    scopus 로고
    • PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2
    • Wishart G.C., Bajdik C.D., Dicks E., et al. PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. Br J Cancer 2012, 107(5):800-807.
    • (2012) Br J Cancer , vol.107 , Issue.5 , pp. 800-807
    • Wishart, G.C.1    Bajdik, C.D.2    Dicks, E.3
  • 52
    • 4344707888 scopus 로고    scopus 로고
    • Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer
    • Fyles A.W., McCready D.R., Manchul L.A., et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. NEngl J Med 2004, 351(10):963-970.
    • (2004) NEngl J Med , vol.351 , Issue.10 , pp. 963-970
    • Fyles, A.W.1    McCready, D.R.2    Manchul, L.A.3
  • 53
    • 4344628403 scopus 로고    scopus 로고
    • Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer
    • Hughes K.S., Schnaper L.A., Berry D., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. NEngl J Med 2004, 351(10):971-977.
    • (2004) NEngl J Med , vol.351 , Issue.10 , pp. 971-977
    • Hughes, K.S.1    Schnaper, L.A.2    Berry, D.3
  • 54
    • 77955859047 scopus 로고    scopus 로고
    • Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer.
    • ASCO Meeting Abstracts. J Clin Oncol 2010;:abstract
    • Hughes KS, Schnaper LA, Cirrincione C, etal. Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer. ASCO Meeting Abstracts. J Clin Oncol 2010;28(Suppl 15):abstract 507.
    • , Issue.28 SUPPL 15 , pp. 507
    • Hughes, K.S.1    Schnaper, L.A.2    Cirrincione, C.3
  • 55
    • 81055155920 scopus 로고    scopus 로고
    • Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials
    • Darby S., McGale P., Correa C., et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011, 378(9804):1707-1716.
    • (2011) Lancet , vol.378 , Issue.9804 , pp. 1707-1716
    • Darby, S.1    McGale, P.2    Correa, C.3
  • 56
    • 84860166698 scopus 로고    scopus 로고
    • Molecular profiling assays in breast cancer: are we ready for prime time?
    • Gokmen-Polar Y., Badve S. Molecular profiling assays in breast cancer: are we ready for prime time?. Oncology 2012, 26(4):350-357.
    • (2012) Oncology , vol.26 , Issue.4 , pp. 350-357
    • Gokmen-Polar, Y.1    Badve, S.2
  • 57
    • 76649099557 scopus 로고    scopus 로고
    • Long-term results of hypofractionated radiation therapy for breast cancer
    • Whelan T.J., Pignol J.P., Levine M.N., et al. Long-term results of hypofractionated radiation therapy for breast cancer. NEngl J Med 2010, 362(6):513-520.
    • (2010) NEngl J Med , vol.362 , Issue.6 , pp. 513-520
    • Whelan, T.J.1    Pignol, J.P.2    Levine, M.N.3
  • 58
    • 79961128669 scopus 로고    scopus 로고
    • Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline
    • Smith B.D., Bentzen S.M., Correa C.R., et al. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 2011, 81(1):59-68.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , Issue.1 , pp. 59-68
    • Smith, B.D.1    Bentzen, S.M.2    Correa, C.R.3
  • 59
    • 67649519727 scopus 로고    scopus 로고
    • Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO)
    • Smith B.D., Arthur D.W., Buchholz T.A., et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009, 74(4):987-1001.
    • (2009) Int J Radiat Oncol Biol Phys , vol.74 , Issue.4 , pp. 987-1001
    • Smith, B.D.1    Arthur, D.W.2    Buchholz, T.A.3
  • 60
    • 0028148836 scopus 로고
    • Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition
    • Anonymous
    • Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet 1994, 55:i-iv. Anonymous.
    • (1994) Am J Hum Genet , vol.55
  • 61
    • 36549075573 scopus 로고    scopus 로고
    • Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology
    • Wildiers H., Kunkler I., Biganzoli L., et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 2007, 8(12):1101-1115.
    • (2007) Lancet Oncol , vol.8 , Issue.12 , pp. 1101-1115
    • Wildiers, H.1    Kunkler, I.2    Biganzoli, L.3
  • 62
    • 78149483057 scopus 로고    scopus 로고
    • Triple-negative breast cancer
    • Foulkes W.D., Smith I.E., Reis J.S. Triple-negative breast cancer. NEngl J Med 2010, 363(20):1938-1948.
    • (2010) NEngl J Med , vol.363 , Issue.20 , pp. 1938-1948
    • Foulkes, W.D.1    Smith, I.E.2    Reis, J.S.3
  • 63
    • 84857530615 scopus 로고    scopus 로고
    • Testing for discordance at metastatic relapse: does it matter?
    • Chia S. Testing for discordance at metastatic relapse: does it matter?. JClin Oncol 2012, 30(6):575-576.
    • (2012) JClin Oncol , vol.30 , Issue.6 , pp. 575-576
    • Chia, S.1
  • 64
    • 4944261201 scopus 로고    scopus 로고
    • Efficacy of first-line letrozole versus tamoxifen as a function of age in postmenopausal women with advanced breast cancer
    • Mouridsen H., Chaudri-Ross H.A. Efficacy of first-line letrozole versus tamoxifen as a function of age in postmenopausal women with advanced breast cancer. Oncologist 2004, 9(5):497-506.
    • (2004) Oncologist , vol.9 , Issue.5 , pp. 497-506
    • Mouridsen, H.1    Chaudri-Ross, H.A.2
  • 65
    • 70349335347 scopus 로고    scopus 로고
    • Management of primary and advanced breast cancer in older unfit patients (medical treatment)
    • Aapro M., Monfardini S., Jirillo A., et al. Management of primary and advanced breast cancer in older unfit patients (medical treatment). Cancer Treat Rev 2009, 35(6):503-508.
    • (2009) Cancer Treat Rev , vol.35 , Issue.6 , pp. 503-508
    • Aapro, M.1    Monfardini, S.2    Jirillo, A.3
  • 66
    • 0026639451 scopus 로고
    • Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience
    • [see comment]
    • Christman K., Muss H.B., Case L.D., et al. Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience. JAMA 1992, 268(1):57-62. [see comment].
    • (1992) JAMA , vol.268 , Issue.1 , pp. 57-62
    • Christman, K.1    Muss, H.B.2    Case, L.D.3
  • 67
    • 0036918281 scopus 로고    scopus 로고
    • Combination versus sequential single-agent therapy in metastatic breast cancer
    • Miles D., von Minckwitz G., Seidman A.D. Combination versus sequential single-agent therapy in metastatic breast cancer. Oncologist 2002, 7(Suppl 6):13-19.
    • (2002) Oncologist , vol.7 , Issue.SUPPL 6 , pp. 13-19
    • Miles, D.1    von Minckwitz, G.2    Seidman, A.D.3
  • 68
    • 0035869407 scopus 로고    scopus 로고
    • Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
    • Slamon D.J., Leyland-Jones B., Shak S., et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. NEngl J Med 2001, 344(11):783-792.
    • (2001) NEngl J Med , vol.344 , Issue.11 , pp. 783-792
    • Slamon, D.J.1    Leyland-Jones, B.2    Shak, S.3
  • 69
    • 84881314387 scopus 로고    scopus 로고
    • Trastuzumab-related cardiotoxicity among older breast cancer patients.
    • ASCO Meeting Abstract. J Clin Oncol
    • Gregor M, Zhang N, Niu J, et al. Trastuzumab-related cardiotoxicity among older breast cancer patients. ASCO Meeting Abstract. J Clin Oncol 2012;30(suppl 27): abstract 135.
    • (2012) , Issue.30 SUPPL 27 , pp. 135
    • Gregor, M.1    Zhang, N.2    Niu, J.3
  • 70
    • 33845886440 scopus 로고    scopus 로고
    • Lapatinib plus capecitabine for HER2-positive advanced breast cancer
    • Geyer C.E., Forster J., Lindquist D., et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. NEngl J Med 2006, 355(26):2733-2743.
    • (2006) NEngl J Med , vol.355 , Issue.26 , pp. 2733-2743
    • Geyer, C.E.1    Forster, J.2    Lindquist, D.3
  • 71
    • 84868520609 scopus 로고    scopus 로고
    • Trastuzumab emtansine for HER2-positive advanced breast cancer
    • Verma S., Miles D., Gianni L., et al. Trastuzumab emtansine for HER2-positive advanced breast cancer. NEngl J Med 2012, 367(19):1783-1791.
    • (2012) NEngl J Med , vol.367 , Issue.19 , pp. 1783-1791
    • Verma, S.1    Miles, D.2    Gianni, L.3
  • 72
    • 84861670957 scopus 로고    scopus 로고
    • Antiresorptive treatment options and bone health in cancer patients-safety profiles and clinical considerations
    • Hadji P., Aapro M., Costa L., et al. Antiresorptive treatment options and bone health in cancer patients-safety profiles and clinical considerations. Cancer Treat Rev 2012, 38(6):815-824.
    • (2012) Cancer Treat Rev , vol.38 , Issue.6 , pp. 815-824
    • Hadji, P.1    Aapro, M.2    Costa, L.3
  • 73
    • 79551568488 scopus 로고    scopus 로고
    • Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study
    • Stopeck A.T., Lipton A., Body J.J., et al. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. JClin Oncol 2010, 28(35):5132-5139.
    • (2010) JClin Oncol , vol.28 , Issue.35 , pp. 5132-5139
    • Stopeck, A.T.1    Lipton, A.2    Body, J.J.3
  • 74
    • 22444444683 scopus 로고    scopus 로고
    • Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review
    • Bauman G., Charette M., Reid R., et al. Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review. Radiother Oncol 2005, 75(3):258-270.
    • (2005) Radiother Oncol , vol.75 , Issue.3 , pp. 258-270
    • Bauman, G.1    Charette, M.2    Reid, R.3
  • 75
    • 77955877759 scopus 로고    scopus 로고
    • Early palliative care for patients with metastatic non-small-cell lung cancer
    • Temel J.S., Greer J.A., Muzikansky A., et al. Early palliative care for patients with metastatic non-small-cell lung cancer. NEngl J Med 2010, 363(8):733-742.
    • (2010) NEngl J Med , vol.363 , Issue.8 , pp. 733-742
    • Temel, J.S.1    Greer, J.A.2    Muzikansky, A.3
  • 76
    • 33847386227 scopus 로고    scopus 로고
    • Comparing hospice and nonhospice patient survival among patients who die within a three-year window
    • Connor S.R., Pyenson B., Fitch K., et al. Comparing hospice and nonhospice patient survival among patients who die within a three-year window. JPain Symptom Manage 2007, 33(3):238-246.
    • (2007) JPain Symptom Manage , vol.33 , Issue.3 , pp. 238-246
    • Connor, S.R.1    Pyenson, B.2    Fitch, K.3
  • 77
    • 0037811742 scopus 로고    scopus 로고
    • Barriers to clinical trial participation by older women with breast cancer
    • Kemeny M.M., Peterson B.L., Kornblith A.B., et al. Barriers to clinical trial participation by older women with breast cancer. JClin Oncol 2003, 21(12):2268-2275.
    • (2003) JClin Oncol , vol.21 , Issue.12 , pp. 2268-2275
    • Kemeny, M.M.1    Peterson, B.L.2    Kornblith, A.B.3
  • 78
    • 32944479538 scopus 로고    scopus 로고
    • Central role of the research nurse in improving accrual of older persons to cancer treatment trials
    • Best I. Central role of the research nurse in improving accrual of older persons to cancer treatment trials. JClin Oncol 2005, 23(30):7752-7753.
    • (2005) JClin Oncol , vol.23 , Issue.30 , pp. 7752-7753
    • Best, I.1
  • 79
    • 0036720874 scopus 로고    scopus 로고
    • Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials
    • Kornblith A.B., Kemeny M., Peterson B.L., et al. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer 2002, 95(5):989-996.
    • (2002) Cancer , vol.95 , Issue.5 , pp. 989-996
    • Kornblith, A.B.1    Kemeny, M.2    Peterson, B.L.3
  • 80
    • 1942421681 scopus 로고    scopus 로고
    • The surgical management of elderly cancer patients; recommendations of the SIOG surgical task force
    • Audisio R.A., Bozzetti F., Gennari R., et al. The surgical management of elderly cancer patients; recommendations of the SIOG surgical task force. Eur J Cancer 2004, 40(7):926-938.
    • (2004) Eur J Cancer , vol.40 , Issue.7 , pp. 926-938
    • Audisio, R.A.1    Bozzetti, F.2    Gennari, R.3
  • 81
    • 37549012238 scopus 로고    scopus 로고
    • Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study
    • Audisio R.A., Pope D., Ramesh H.S., et al. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol 2008, 65(2):156-163.
    • (2008) Crit Rev Oncol Hematol , vol.65 , Issue.2 , pp. 156-163
    • Audisio, R.A.1    Pope, D.2    Ramesh, H.S.3
  • 82
    • 34249794845 scopus 로고    scopus 로고
    • Radiation therapy and the geriatric oncology patient
    • Horiot J.C. Radiation therapy and the geriatric oncology patient. JClin Oncol 2007, 25(14):1930-1935.
    • (2007) JClin Oncol , vol.25 , Issue.14 , pp. 1930-1935
    • Horiot, J.C.1
  • 83
    • 34249779624 scopus 로고    scopus 로고
    • International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients-an analysis of the medical literature
    • Lichtman S.M., Wildiers H., Chatelut E., et al. International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients-an analysis of the medical literature. JClin Oncol 2007, 25(14):1832-1843.
    • (2007) JClin Oncol , vol.25 , Issue.14 , pp. 1832-1843
    • Lichtman, S.M.1    Wildiers, H.2    Chatelut, E.3
  • 84
    • 0038662715 scopus 로고    scopus 로고
    • Participation of patients 65 years of age or older in cancer clinical trials
    • Lewis J.H., Kilgore M.L., Goldman D.P., et al. Participation of patients 65 years of age or older in cancer clinical trials. JClin Oncol 2003, 21(7):1383-1389.
    • (2003) JClin Oncol , vol.21 , Issue.7 , pp. 1383-1389
    • Lewis, J.H.1    Kilgore, M.L.2    Goldman, D.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.